UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.59B |
| 2 |
AGN
Allergan plc
AGN
|
+$763M |
| 3 |
Boeing
BA
|
+$639M |
| 4 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$542M |
| 5 |
Apple
AAPL
|
+$402M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$377M |
| 2 |
Ecolab
ECL
|
+$332M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$315M |
| 4 |
iShares US Treasury Bond ETF
GOVT
|
+$306M |
| 5 |
CELG
Celgene Corp
CELG
|
+$250M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.74% |
| 2 | Financials | 7.41% |
| 3 | Healthcare | 6.49% |
| 4 | Consumer Discretionary | 5.87% |
| 5 | Industrials | 5.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4776
State Street SPDR FactSet Innovative Technology ETF
XITK
$74.9M
| $244K | ﹤0.01% |
2,306
+1,712
| +288% | +$180K |
|
|
DCH
4777
Dauch Corp
DCH
$1.35B
| $243K | ﹤0.01% |
19,079
+11,815
| +163% | +$154K |
|
4778
Camtek
CAMT
$6.98B
| $243K | ﹤0.01% |
28,802
+22,421
| +351% | +$207K |
|
|
DCPH
4779
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $243K | ﹤0.01% |
10,757
+2,927
| +37% | +$68.5K |
|
4780
Cytokinetics
CYTK
$11B
| $242K | ﹤0.01% |
21,528
+16,569
| +334% | +$160K |
|
4781
Wipro
WIT
$19.7B
| $242K | ﹤0.01% |
111,818
-215,490
| -66% | -$474K |
|
4782
Acco Brands
ACCO
$407M
| $241K | ﹤0.01% |
30,557
+23,735
| +348% | +$195K |
|
4783
PUT
Diageo
DEO
$51.6B
| $241K | ﹤0.01% |
1,400
+500
| +56% | +$84K |
|
4784
iShares Future Exponential Technologies ETF
XT
$3.91B
| $241K | ﹤0.01% |
6,259
-8
| -0.1% | -$304 |
|
|
HNGR
4785
DELISTED
Hanger Inc.
HNGR
| $241K | ﹤0.01% |
12,587
-814
| -6% | -$15.8K |
|
4786
CALL
Apollo Global Management
APO
$73.7B
| $240K | ﹤0.01% |
+7,000
| New | +$222K |
|
4787
Arrow Financial
AROW
$661M
| $240K | ﹤0.01% |
8,023
-1,255
| -14% | -$36.3K |
|
4788
Coca-Cola Consolidated
COKE
$12.5B
| $240K | ﹤0.01% |
8,030
-5,500
| -41% | -$172K |
|
|
GPMT
4789
PUT
Granite Point Mortgage Trust
GPMT
$60.2M
| $240K | ﹤0.01% |
+12,500
| New | +$238K |
|
4790
Hamilton Lane
HLNE
$5.43B
| $240K | ﹤0.01% |
4,210
+2,433
| +137% | +$122K |
|
|
JMIA
4791
Jumia Technologies
JMIA
$705M
| $240K | ﹤0.01% |
+9,093
| New | +$262K |
|
4792
Wabash National
WNC
$512M
| $240K | ﹤0.01% |
14,783
-325,525
| -96% | -$4.79M |
|
|
BMTC
4793
DELISTED
Bryn Mawr Bank Corp
BMTC
| $240K | ﹤0.01% |
6,437
+5,137
| +395% | +$192K |
|
4794
Invesco S&P SmallCap Energy ETF
PSCE
$97.4M
| $239K | ﹤0.01% |
5,319
-1
| -0% | -$49 |
|
|
FISK
4795
Empire State Realty OP LP Series 250
FISK
$1.46B
| $238K | ﹤0.01% |
16,167
-699
| -4% | -$10.7K |
|
4796
Hawkins
HWKN
$2.71B
| $238K | ﹤0.01% |
10,968
+7,092
| +183% | +$136K |
|
4797
Kforce
KFRC
$1.05B
| $238K | ﹤0.01% |
6,777
+6,572
| +3,206% | +$236K |
|
4798
Children's Place
PLCE
$58.9M
| $238K | ﹤0.01% |
2,495
-60,647
| -96% | -$6.19M |
|
|
TNAV
4799
DELISTED
Telenav Inc.
TNAV
| $238K | ﹤0.01% |
29,673
+4,755
| +19% | +$33.1K |
|
4800
PUT
First Majestic Silver
AG
$8.52B
| $237K | ﹤0.01% |
30,000
-2,200
| -7% | -$13.9K |
|
Similar funds
UBS Group's Q2 2019 Portfolio in Review
As of Q2 2019, UBS Group held 8,581 positions worth $260B, up 7.3% from $242B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group deployed $9.95B of net new capital in Q2 2019, opening 809 new positions and adding to 3,918 existing holdings. Its largest new stake was Dow Inc: 4,472,376 shares worth $221M.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9.6% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $377M trimmed.
- UBS Group's largest Q2 2019 buy was Dow Inc: 4,472,376 shares worth $221M.
- UBS Group added most to UBS Group in Q2 2019, an estimated $1.59B increase.
- UBS Group's biggest Q2 2019 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $377M.
- UBS Group fully exited Bemis in Q2 2019, selling an estimated $102M.
- UBS Group's ten largest holdings make up 14% of its $260B portfolio in Q2 2019.
- UBS Group opened 809 new positions and closed 626 in Q2 2019.
- UBS Group's portfolio value rose 7.3% quarter-over-quarter to $260B.
Based on UBS Group's 13F filing for Q2 2019, filed 14 Aug 2019.